Correlation Between Adaptimmune Therapeutics and Actinium Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Actinium Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Actinium Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Actinium Pharmaceuticals, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Actinium Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Actinium Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Actinium Pharmaceuticals.
Diversification Opportunities for Adaptimmune Therapeutics and Actinium Pharmaceuticals
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Adaptimmune and Actinium is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Actinium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinium Pharmaceuticals and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Actinium Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinium Pharmaceuticals has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Actinium Pharmaceuticals go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Actinium Pharmaceuticals
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to generate 1.61 times more return on investment than Actinium Pharmaceuticals. However, Adaptimmune Therapeutics is 1.61 times more volatile than Actinium Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Actinium Pharmaceuticals is currently generating about -0.26 per unit of risk. If you would invest 70.00 in Adaptimmune Therapeutics Plc on August 30, 2024 and sell it today you would earn a total of 3.00 from holding Adaptimmune Therapeutics Plc or generate 4.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Actinium Pharmaceuticals
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Actinium Pharmaceuticals |
Adaptimmune Therapeutics and Actinium Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Actinium Pharmaceuticals
The main advantage of trading using opposite Adaptimmune Therapeutics and Actinium Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Actinium Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinium Pharmaceuticals will offset losses from the drop in Actinium Pharmaceuticals' long position.The idea behind Adaptimmune Therapeutics Plc and Actinium Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Actinium Pharmaceuticals vs. Mink Therapeutics | Actinium Pharmaceuticals vs. Affimed NV | Actinium Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Actinium Pharmaceuticals vs. Sangamo Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world |